| Year |
Citation |
Score |
| 2024 |
Guo N, Li X, Movahedi M, Cesta A, Bombardier C. Biologics initiation in moderate versus severe rheumatoid arthritis: real-world experience from a Canadian registry. Clinical and Experimental Rheumatology. PMID 38372710 DOI: 10.55563/clinexprheumatol/mpevid |
0.316 |
|
| 2023 |
Akhavan PS, Movahedi M, Cesta A, Bombardier C. Factors affecting the discrepancy between patient and physician global assessment in early rheumatoid arthritis: The Ontario Best Practices Research Initiative. Clinical and Experimental Rheumatology. PMID 37382462 DOI: 10.55563/clinexprheumatol/r7b8go |
0.326 |
|
| 2023 |
Wong-Pack M, Hepworth E, Movahedi M, Kuriya B, Pope J, Keystone E, Thorne C, Ahluwalia V, Cesta A, Mously C, Bombardier C, Lau A, Aydin SZ. Impact of the COVID-19 pandemic on patients with rheumatoid arthritis: data from the Ontario Best Practices Research Initiative (OBRI). Rheumatology Advances in Practice. 7: rkad042. PMID 37179654 DOI: 10.1093/rap/rkad042 |
0.315 |
|
| 2022 |
Li X, Cesta A, Movahedi M, Bombardier C. Late-onset rheumatoid arthritis has a similar time to remission as younger-onset rheumatoid arthritis: results from the Ontario Best Practices Research Initiative. Arthritis Research & Therapy. 24: 255. PMID 36401335 DOI: 10.1186/s13075-022-02952-1 |
0.346 |
|
| 2022 |
Pope J, Hall S, Bombardier C, Haraoui B, Jones G, Naik L, Etzel CJ, Ramey DR, Infante R, Miguelez M, Falcao S, Sahakian S, Wu D. Post-switch Effectiveness of Etanercept Biosimilar Versus Continued Etanercept in Rheumatoid Arthritis Patients with Stable Disease: A Prospective Multinational Observational Study. Advances in Therapy. PMID 36136243 DOI: 10.1007/s12325-022-02303-1 |
0.351 |
|
| 2022 |
Hazlewood GS, Pardo JP, Barnabe C, Schieir O, Barber CEH, Proulx L, Richards DP, Tugwell P, Bansback N, Akhavan P, Bombardier C, Bykerk V, Jamal S, Khraishi M, Taylor-Gjevre R, et al. Canadian Rheumatology Association living guidelines for the pharmacological management of rheumatoid arthritis with disease-modifying anti-rheumatic drugs. The Journal of Rheumatology. PMID 35840155 DOI: 10.3899/jrheum.220209 |
0.329 |
|
| 2022 |
Movahedi M, Cesta A, Li X, Keystone EC, Bombardier C. Physician- and Patient-reported Effectiveness Are Similar for Tofacitinib and TNFi in Rheumatoid Arthritis: Data From a Rheumatoid Arthritis Registry. The Journal of Rheumatology. PMID 35169051 DOI: 10.3899/jrheum.211066 |
0.351 |
|
| 2021 |
Hazlewood GS, Bombardier C, Li X, Movahedi M, Choquette D, Coupal L, Bykerk V, Schieir O, Mosher D, Marshall DA, Bernatsky S, Spencer N, Richards DP, Proulx L, Barber CEH, et al. Heterogeneity in patient characteristics and differences in treatment across four Canadian rheumatoid arthritis cohorts. The Journal of Rheumatology. PMID 34334357 DOI: 10.3899/jrheum.201688 |
0.352 |
|
| 2020 |
Movahedi M, Hepworth E, Mirza R, Cesta A, Larche M, Bombardier C. Discontinuation of biologic therapy due to lack/loss of response and adverse events is similar between TNFi and non-TNFi class: Results from a real-world rheumatoid arthritis cohort. Seminars in Arthritis and Rheumatism. 50: 915-922. PMID 32911288 DOI: 10.1016/J.Semarthrit.2020.06.020 |
0.37 |
|
| 2020 |
Pope JE, Rampakakis E, Movahedi M, Cesta A, Sampalis JS, Bombardier C. Time to remission in swollen joints is far faster than patient reported outcomes in rheumatoid arthritis: results from the Ontario Best Practices Research Initiative (OBRI). Rheumatology (Oxford, England). PMID 32789456 DOI: 10.1093/Rheumatology/Keaa343 |
0.439 |
|
| 2020 |
Pope J, Movahedi M, Rampakakis E, Cesta A, Sampalis J, Bombardier C. Sat0049 Differences Between Early And Established Rheumatoid Arthritis In Time To Achieving Cdai But Not Fatigue Low Disease Activity And Remission: Data From The Obri Registry Annals of the Rheumatic Diseases. 79: 951-952. DOI: 10.1136/Annrheumdis-2020-Eular.1751 |
0.481 |
|
| 2019 |
Tatangelo M, Tomlinson G, Paterson JM, Ahluwalia V, Kopp A, Gomes T, Bansback N, Bombardier C. Association of Patient, Prescriber, and Region With the Initiation of First Prescription of Biologic Disease-Modifying Antirheumatic Drug Among Older Patients With Rheumatoid Arthritis and Identical Health Insurance Coverage. Jama Network Open. 2: e1917053. PMID 31808927 DOI: 10.1001/jamanetworkopen.2019.17053 |
0.335 |
|
| 2019 |
Keystone E, Rampakakis E, Movahedi M, Cesta A, Stutz M, Sampalis JS, Nantel F, Maslova K, Bombardier C. Towards Defining Primary and Secondary Non-Response in Rheumatoid Arthritis Patients Treated with Anti-TNFs: Results from the BioTRAC and OBRI Registries. The Journal of Rheumatology. PMID 31263067 DOI: 10.3899/Jrheum.190102 |
0.363 |
|
| 2019 |
Movahedi M, Cesta A, Li X, Bombardier C. Collection of Anti-Rheumatic Medication Data from Both Patients and Rheumatologists Shows Strong Agreement in a Real World Clinical Cohort: The Ontario Best Practices Research Initiative (OBRI) a Rheumatoid Arthritis Cohort. Journal of Clinical Epidemiology. PMID 31226411 DOI: 10.1016/J.Jclinepi.2019.06.012 |
0.377 |
|
| 2019 |
Ahluwalia V, Brooks S, Sweezie R, Bell M, Kendzerska T, Widdifield J, Bombardier C. The Effect of Triage Assessments on Identifying Inflammatory Arthritis and Reducing Rheumatology Wait Times in Ontario. The Journal of Rheumatology. PMID 31154411 DOI: 10.3899/Jrheum.180734 |
0.63 |
|
| 2019 |
Lau AN, Thorne JC, Movahedi M, Rampakakis E, Cesta A, Li X, Couto S, Sampalis J, Bombardier C. Effect of Concomitant Disease-modifying Antirheumatic Drugs and Methotrexate Administration Route on Biologic Treatment Durability in Rheumatoid Arthritis: OBRI Cohort Results. The Journal of Rheumatology. PMID 30988121 DOI: 10.3899/jrheum.180486 |
0.318 |
|
| 2019 |
Hepworth E, Movahedi M, Rampakakis E, Mirza R, Lau A, Cesta A, Pope J, Bombardier C. Thu0163 A Descriptive Analysis Of Longitudinal Changes In Relative Market Share Proportions Of Biologic And Targeted Synthetic Disease-Modifying Anti-Rheumatic Drugs For Treatment Of Rheumatoid Arthritis: Data From The Obri Database Annals of the Rheumatic Diseases. 78: 355-355. DOI: 10.1136/Annrheumdis-2019-Eular.8100 |
0.367 |
|
| 2019 |
Movahedi M, Cesta A, Xiuying L, Bombardier C. Fri0163 Time To Discontinuation Of Tofacitinab In Patients With Rheumatoid Arthritis With And Without Methotrexate: Results From The Ontario Best Practices Research Initiative (Obri) Cohort Annals of the Rheumatic Diseases. 78: 754-754. DOI: 10.1136/Annrheumdis-2019-Eular.4985 |
0.38 |
|
| 2019 |
Akhavan P, Movahedi M, Bombardier C. Thu0126 Factors Affecting The Discrepancy Between Patient And Physician Global Assessment Of Disease Activity In Patients With Early Rheumatoid Arthritis Over Time Annals of the Rheumatic Diseases. 78: 335-336. DOI: 10.1136/Annrheumdis-2019-Eular.4888 |
0.405 |
|
| 2019 |
Taylor PC, Christensen R, Moosavi S, Selema P, Guilatco R, Fowler H, Bombardier C, Haraoui B. Fri0122 Real-World Safety Data From Patients With Rheumatic Diseases Treated With Ct-P13, An Infliximab Biosimilar: An Interim Analysis From An Observational Study Annals of the Rheumatic Diseases. 78: 729-729. DOI: 10.1136/Annrheumdis-2019-Eular.2655 |
0.357 |
|
| 2019 |
Cui K, Movahedi M, Bombardier C, Kuriya B. Thu0125 Cardiovascular Disease Risk Factors May Negatively Impact Rheumatoid Arthritis Disease Outcomes: Findings From The Ontario Best Practices Research Initiative Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2019-Eular.2484 |
0.347 |
|
| 2019 |
Cui K, Movahedi M, Bombardier C, Kuriya B. Fri0029 Development Of An Algorithm For The Classification Of Cardiovascular Comorbidity In Rheumatoid Arthritis: Data From The Ontario Best Practices Research Initiative Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2019-Eular.2479 |
0.35 |
|
| 2018 |
Pope JE, Movahedi M, Rampakakis E, Cesta A, Sampalis JS, Keystone E, Thorne C, Bombardier C. ACPA and RF as predictors of sustained clinical remission in patients with rheumatoid arthritis: data from the Ontario Best practices Research Initiative (OBRI). Rmd Open. 4: e000738. PMID 30487995 DOI: 10.1136/rmdopen-2018-000738 |
0.334 |
|
| 2018 |
Joshi R, Movahedi M, Rampakakis E, Thorne C, Cesta A, Sampalis JS, Bombardier C. THU0126 Impact of residential area on the profile of rheumatoid arthritis patients initiating their first biologic dmard: results from the ontario best practices research initiative (OBRI) Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2018-Eular.2194 |
0.401 |
|
| 2018 |
Pope JE, Movahedi M, Rampakakis E, Cesta A, Sampalis JS, Bombardier C. SAT0073 Acpa and rf as predictors of sustained clinical remission in rheumatoid arthritis patients: results from the ontario best practices research initiative (OBRI) Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2018-Eular.2141 |
0.407 |
|
| 2018 |
Movahedi M, Cesta A, Li X, Bombardier C. SAT0704 Collection of anti-rheumatic medication data from both patients and rheumatologists shows strong agreement in a real world clinical cohort: results from the ontario best practices research initiative (OBRI) Annals of the Rheumatic Diseases. 77: 1200-1200. DOI: 10.1136/Annrheumdis-2018-Eular.2136 |
0.383 |
|
| 2017 |
Pope JE, Rampakakis E, Movahedi M, Cesta A, Li X, Couto S, Sampalis JS, Bombardier C. Treatment patterns in rheumatoid arthritis after discontinuation of methotrexate: data from the Ontario Best Practices Research Initiative (OBRI). Clinical and Experimental Rheumatology. PMID 29148403 |
0.343 |
|
| 2017 |
Hazlewood GS, Bombardier C, Tomlinson G, Marshall D. A Bayesian model that jointly considers comparative effectiveness research and patients' preferences may help inform GRADE recommendations: An application to rheumatoid arthritis treatment recommendations. Journal of Clinical Epidemiology. PMID 29051108 DOI: 10.1016/J.Jclinepi.2017.10.003 |
0.371 |
|
| 2017 |
Barber CEH, Mosher DP, Ahluwalia V, Zummer M, Marshall DA, Choquette D, Lacaille D, Bombardier C, Lyddiatt A, Chandran V, Khodyakov D, Dao E, Barnabe C. Development of a Canadian Core Clinical Dataset to Support High-quality Care for Canadian Patients with Rheumatoid Arthritis. The Journal of Rheumatology. PMID 28966205 DOI: 10.3899/Jrheum.170421 |
0.39 |
|
| 2017 |
Ahluwalia V, Rampakakis E, Movahedi M, Cesta A, Li X, Sampalis JS, Bombardier C. Predictors of patient decision to discontinue anti-rheumatic medication in patients with rheumatoid arthritis: results from the Ontario best practices research initiative. Clinical Rheumatology. PMID 28879413 DOI: 10.1007/S10067-017-3805-4 |
0.436 |
|
| 2017 |
Joshi R, Movahedi M, Rampakakis E, Cesta A, Li X, Couto S, Sampalis J, Bombardier C, Kuriya B. FRI0132 High disease activity is a predictor of depression and persistent depression in early rheumatoid arthritis: results from the ontario best practices research initiative (OBRI) Annals of the Rheumatic Diseases. 76. DOI: 10.1136/Annrheumdis-2017-Eular.2311 |
0.326 |
|
| 2017 |
Ahluwalia V, Movahedi M, Rampakakis E, Cesta A, Li X, Couto S, Sampalis J, Bombardier C. OP0337-HPR Predictors of patient reported decision to discontinue anti-rheumatic medication in rheumatoid arthritis patients: data from a rheumatoid arthritis cohort Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2017-Eular.1522 |
0.427 |
|
| 2016 |
Widdifield J, Ivers NM, Bernatsky S, Jaakkimainen RL, Bombardier C, Thorne JC, Ahluwalia V, Paterson JM, Young J, Wing L, Tu K. Primary Care Screening and Management of Comorbidity in Rheumatoid Arthritis in Ontario, Canada. Arthritis Care & Research. PMID 27998044 DOI: 10.1002/Acr.23178 |
0.673 |
|
| 2016 |
Hazlewood GS, Bombardier C, Tomlinson G, Thorne C, Bykerk VP, Thompson A, Tin D, Marshall DA. Treatment preferences of patients with early rheumatoid arthritis: a discrete-choice experiment. Rheumatology (Oxford, England). PMID 27477807 DOI: 10.1093/Rheumatology/Kew280 |
0.424 |
|
| 2016 |
Widdifield J, Bernatsky S, Thorne JC, Bombardier C, Jaakkimainen RL, Wing L, Paterson JM, Ivers N, Butt D, Lyddiatt A, Hofstetter C, Ahluwalia V, Tu K. Wait times to rheumatology care for patients with rheumatic diseases: a data linkage study of primary care electronic medical records and administrative data. Cmaj Open. 4: E205-12. PMID 27398365 DOI: 10.9778/cmajo.20150116 |
0.57 |
|
| 2016 |
Widdifield J, Tu K, Thorne JC, Bombardier C, Paterson JM, Jaakkimainen RL, Wing L, Butt DA, Ivers N, Hofstetter C, Lyddiatt A, Ahluwalia V, Bernatsky S. Patterns of care among first-time referrals to rheumatologists: Characteristics and timeliness of consultations and treatment in Ontario, Canada. Arthritis Care & Research. PMID 27110847 DOI: 10.1002/Acr.22910 |
0.6 |
|
| 2016 |
Hazlewood GS, Barnabe C, Tomlinson G, Marshall D, Devoe D, Bombardier C. Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysis. Bmj (Clinical Research Ed.). 353: i1777. PMID 27102806 DOI: 10.1136/Bmj.I1777 |
0.408 |
|
| 2016 |
Widdifield J, Moura CS, Wang Y, Abrahamowicz M, Paterson JM, Huang A, Beauchamp ME, Boire G, Fortin PR, Bessette L, Bombardier C, Hanly JG, Feldman D, Bernatsky S. The Longterm Effect of Early Intensive Treatment of Seniors with Rheumatoid Arthritis: A Comparison of 2 Population-based Cohort Studies on Time to Joint Replacement Surgery. The Journal of Rheumatology. PMID 26879353 DOI: 10.3899/Jrheum.151156 |
0.674 |
|
| 2016 |
Lau AN, Movahedi M, Tatengelo M, Bombardier C. FRI0159 Persistence with Biologic Monotherapy in Comparison with Combination Therapy with Disease-Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis; Results from An Ontario Rheumatoid Arthritis Cohort Annals of the Rheumatic Diseases. 75: 486-487. DOI: 10.1136/Annrheumdis-2016-Eular.4257 |
0.45 |
|
| 2016 |
Rohekar G, Movahedi M, Pope JE, Bombardier C. AB0191 Durability of First Biologic Disease-Modifying Antirheumatic Drug Is Not Influenced by Initial/early DAS28 Annals of the Rheumatic Diseases. 75: 962-963. DOI: 10.1136/Annrheumdis-2016-Eular.4242 |
0.414 |
|
| 2015 |
Widdifield J, Bernatsky S, Bombardier C, Paterson M. Rheumatoid Arthritis Surveillance in Ontario: Monitoring the Burden, Quality of Care and Patient Outcomes through Linkage of Administrative Health Data. Healthcare Quarterly (Toronto, Ont.). 18: 7-10. PMID 26718246 DOI: 10.12927/Hcq.2015.24439 |
0.701 |
|
| 2015 |
Beaton DE, Dyer S, Boonen A, Verstappen SM, Escorpizo R, Lacaille DV, Bosworth A, Gignac MA, Leong A, Purcaru O, Leggett S, Hofstetter C, Peterson IF, Tang K, Fautrel B, ... Bombardier C, et al. OMERACT Filter Evidence Supporting the Measurement of At-work Productivity Loss as an Outcome Measure in Rheumatology Research. The Journal of Rheumatology. PMID 26329339 DOI: 10.3899/Jrheum.141077 |
0.495 |
|
| 2015 |
Ruban TN, Jacob B, Pope JE, Keystone EC, Bombardier C, Kuriya B. The influence of age at disease onset on disease activity and disability: results from the Ontario Best Practices Research Initiative. Clinical Rheumatology. PMID 26245721 DOI: 10.1007/S10067-015-3031-X |
0.463 |
|
| 2015 |
Moura CS, Abrahamowicz M, Beauchamp ME, Lacaille D, Wang Y, Boire G, Fortin PR, Bessette L, Bombardier C, Widdifield J, Hanly JG, Feldman D, Maksymowych W, Peschken C, Barnabe C, et al. Early medication use in new-onset rheumatoid arthritis may delay joint replacement: results of a large population-based study. Arthritis Research & Therapy. 17: 197. PMID 26235697 DOI: 10.1186/S13075-015-0713-3 |
0.675 |
|
| 2015 |
Brode SK, Jamieson FB, Ng R, Campitelli MA, Kwong JC, Paterson JM, Li P, Marchand-Austin A, Bombardier C, Marras TK. Increased risk of mycobacterial infections associated with anti-rheumatic medications. Thorax. 70: 677-82. PMID 25911222 DOI: 10.1136/Thoraxjnl-2014-206470 |
0.334 |
|
| 2015 |
Widdifield J, Bernatsky S, Paterson JM, Tomlinson G, Tu K, Kuriya B, Thorne JC, Pope JE, Hollands S, Bombardier C. Trends in excess mortality among patients with rheumatoid arthritis in ontario, Canada. Arthritis Care & Research. PMID 25623141 DOI: 10.1002/Acr.22553 |
0.674 |
|
| 2015 |
Bellamy N, Hochberg M, Tubach F, Martin-Mola E, Awada H, Bombardier C, Hajjaj-Hassouni N, Logeart I, Matucci-Cerinic M, van de Laar M, van der Heijde D, Dougados M. Development of multinational definitions of minimal clinically important improvement and patient acceptable symptomatic state in osteoarthritis. Arthritis Care & Research. 67: 972-80. PMID 25581339 DOI: 10.1002/Acr.22538 |
0.321 |
|
| 2015 |
Moura CS, Abrahamowicz M, Beauchamp ME, Lacaille D, Wang Y, Boire G, Fortin PR, Bessette L, Bombardier C, Widdifield J, Hanly JG, Feldman D, Maksymowych W, Peschken C, Barnabe C, et al. Early medication use in new-onset rheumatoid arthritis may delay joint replacement: Results of a large population-based study Arthritis Research and Therapy. 17. DOI: 10.1186/s13075-015-0713-3 |
0.602 |
|
| 2015 |
Widdifield J, Abrahamowicz M, Paterson M, Bombardier C, Tomlinson G, Huang A, Kuriya B, Bernatsky S. THU0348 The Influence of Drug Exposures and Comorbidity on Survival in Patients with Rheumatoid Arthritis Annals of the Rheumatic Diseases. 74: 321.2-321. DOI: 10.1136/Annrheumdis-2015-Eular.5089 |
0.673 |
|
| 2015 |
Widdifield J, Moura C, Wang Y, Abrahamowicz M, Beauchamp M, Paterson M, Huang A, Boire G, Fortin P, Bessette L, Bombardier C, Hanly J, Feldman D, Bernatsky S. OP0020 The Influence of Drug Exposures on Joint Surgeries in Rheumatoid Arthritis Patients: Cross-Provincial Comparisons Annals of the Rheumatic Diseases. 74: 72.1-72. DOI: 10.1136/Annrheumdis-2015-Eular.4981 |
0.666 |
|
| 2015 |
Widdifield J, Bernatsky S, Paterson M, Abrahamowicz M, Kuriya B, Tomlinson G, Tatangelo M, Thorne C, Pope J, Luo J, Bombardier C. SAT0347 Comparisons of Reporting and Level of Agreement of Co-Morbidities Ascertained from Rheumatologists, Patients and Health Administrative Data: A Data Linkage Study Among Patients with Rheumatoid Arthritis Annals of the Rheumatic Diseases. 74: 784.2-785. DOI: 10.1136/Annrheumdis-2015-Eular.4798 |
0.63 |
|
| 2015 |
Tatangelo M, Tomlinson G, Kuriya B, Bombardier C. FRI0336 Disease Activity Patterns in Rheumatoid Arthritis in the First 3-Years of Follow-Up in Usual Care: Markov Modeling Shows Rapid Improvement in DAS28 States in the 1st Year Followed by Stable States in the Last 2 Years. Results from the Ontario Best Practices Research Initiative (OBRI) Annals of the Rheumatic Diseases. 74: 546-547. DOI: 10.1136/Annrheumdis-2015-Eular.4293 |
0.377 |
|
| 2015 |
Cui K, Jacob B, Widdifield J, Pope J, Kuriya B, Akhavan P, Bombardier C. SAT0119 Prevalence of Cardiovascular Disease and its Associations with Disease Severity in Rheumatoid Arthritis Patients – Data from the Ontario Best Practices Research Initiative (OBRI) Annals of the Rheumatic Diseases. 74: 693.2-693. DOI: 10.1136/Annrheumdis-2015-Eular.3244 |
0.691 |
|
| 2014 |
Berard RA, Tomlinson G, Li X, Oen K, Rosenberg AM, Feldman BM, Yeung RS, Bombardier C. Description of active joint count trajectories in juvenile idiopathic arthritis. The Journal of Rheumatology. 41: 2466-73. PMID 25274882 DOI: 10.3899/Jrheum.130835 |
0.367 |
|
| 2014 |
Hazlewood GS, Akhavan P, Schieir O, Marshall D, Tomlinson G, Bykerk V, Bombardier C. Adding a "GRADE" to the quality appraisal of rheumatoid arthritis guidelines identifies limitations beyond AGREE-II. Journal of Clinical Epidemiology. 67: 1274-85. PMID 25240769 DOI: 10.1016/J.Jclinepi.2014.07.005 |
0.4 |
|
| 2014 |
Widdifield J, Bombardier C, Bernatsky S, Paterson JM, Green D, Young J, Ivers N, Butt DA, Jaakkimainen RL, Thorne JC, Tu K. An administrative data validation study of the accuracy of algorithms for identifying rheumatoid arthritis: the influence of the reference standard on algorithm performance. Bmc Musculoskeletal Disorders. 15: 216. PMID 24956925 DOI: 10.1186/1471-2474-15-216 |
0.643 |
|
| 2014 |
Widdifield J, Paterson JM, Bernatsky S, Tu K, Tomlinson G, Kuriya B, Thorne JC, Bombardier C. The epidemiology of rheumatoid arthritis in Ontario, Canada. Arthritis & Rheumatology (Hoboken, N.J.). 66: 786-93. PMID 24757131 DOI: 10.1002/Art.38306 |
0.675 |
|
| 2014 |
Widdifield J, Paterson JM, Bernatsky S, Tu K, Thorne JC, Ivers N, Butt D, Jaakkimainen RL, Gunraj N, Ahluwalia V, Bombardier C. Access to rheumatologists among patients with newly diagnosed rheumatoid arthritis in a Canadian universal public healthcare system. Bmj Open. 4: e003888. PMID 24486677 DOI: 10.1136/Bmjopen-2013-003888 |
0.686 |
|
| 2014 |
Brode SK, Jamieson FB, Ng R, Campitelli MA, Kwong JC, Paterson JM, Li P, Marchand-Austin A, Bombardier C, Marras TK. Risk of mycobacterial infections associated with rheumatoid arthritis in Ontario, Canada. Chest. 146: 563-72. PMID 24384637 DOI: 10.1378/Chest.13-2058 |
0.4 |
|
| 2014 |
Tang K, Boonen A, Verstappen SM, Escorpizo R, Luime JJ, Lacaille D, Fautrel B, Bosworth A, Cifaldi M, Gignac MA, Hofstetter C, Leong A, Montie P, Petersson IF, Purcaru O, ... Bombardier C, et al. Worker productivity outcome measures: OMERACT filter evidence and agenda for future research. The Journal of Rheumatology. 41: 165-76. PMID 24128774 DOI: 10.3899/Jrheum.130815 |
0.45 |
|
| 2014 |
Sivera F, Andrés M, Carmona L, Kydd AS, Moi J, Seth R, Sriranganathan M, van Durme C, van Echteld I, Vinik O, Wechalekar MD, Aletaha D, Bombardier C, Buchbinder R, Edwards CJ, et al. Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative. Annals of the Rheumatic Diseases. 73: 328-35. PMID 23868909 DOI: 10.1136/Annrheumdis-2013-203325 |
0.31 |
|
| 2014 |
Hazlewood G, Jacob B, Akhavan P, Bombardier C. THU0255 Methotrexate Parenteral Administration versus Oral Delivery: A Comparison of Treatment Survival Using Ontario Best Practice Research Initiative (OBRI) Cohort Annals of the Rheumatic Diseases. 73: 270-271. DOI: 10.1136/Annrheumdis-2014-Eular.5560 |
0.425 |
|
| 2014 |
Widdifield J, Young J, Bombardier C, Jaakkimainen R, Butt D, Ivers N, Bernatsky S, Paterson J, Thorne J, Ahluwalia V, Tomlinson G, Tu K. FRI0194 Identifying Patients with Rheumatoid Arthritis in Primary Care Electronic Medical Records Annals of the Rheumatic Diseases. 73: 452.3-453. DOI: 10.1136/Annrheumdis-2014-Eular.4816 |
0.692 |
|
| 2014 |
Moura C, Abrahamowicz M, Beauchamp M, Lacaille D, Wang Y, Bombardier C, Widdifield J, Hanly J, Boire G, Feldman D, Maksymowych W, Peschken C, Barnabe C, Edworthy S, Fortin P, et al. THU0120 Is Early DMARD Use Associated with Less Joint Replacement Surgery? an Analysis of 5,199 Incident Rheumatoid Arthritis (RA) Patients Annals of the Rheumatic Diseases. 73: 219.2-220. DOI: 10.1136/Annrheumdis-2014-Eular.3061 |
0.695 |
|
| 2013 |
Widdifield J, Paterson JM, Bernatsky S, Tu K, Thorne JC, Ahluwalia V, Ivers N, Butt D, Jaakkimainen RL, Tomlinson G, Bombardier C. The rising burden of rheumatoid arthritis surpasses rheumatology supply in Ontario. Canadian Journal of Public Health = Revue Canadienne De Santé Publique. 104: e450-5. PMID 24495819 DOI: 10.17269/Cjph.104.4115 |
0.67 |
|
| 2013 |
Hazlewood GS, Naimark D, Gardam M, Bykerk V, Bombardier C. Prophylaxis for latent tuberculosis infection prior to anti–tumor necrosis factor therapy in low-risk elderly patients with rheumatoid arthritis: a decision analysis. Arthritis Care & Research. 65: 1722-31. PMID 23836530 DOI: 10.1002/Acr.22063 |
0.366 |
|
| 2013 |
Shea B, Swinden MV, Tanjong Ghogomu E, Ortiz Z, Katchamart W, Rader T, Bombardier C, Wells GA, Tugwell P. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. The Cochrane Database of Systematic Reviews. 5: CD000951. PMID 23728635 DOI: 10.1002/14651858.Cd000951.Pub2 |
0.386 |
|
| 2013 |
Widdifield J, Bernatsky S, Paterson JM, Tu K, Ng R, Thorne JC, Pope JE, Bombardier C. Accuracy of Canadian health administrative databases in identifying patients with rheumatoid arthritis: a validation study using the medical records of rheumatologists. Arthritis Care & Research. 65: 1582-91. PMID 23592598 DOI: 10.1002/Acr.22031 |
0.69 |
|
| 2013 |
Tang K, Beaton DE, Lacaille D, Gignac MA, Bombardier C. Sensibility of five at-work productivity measures was endorsed by patients with osteoarthritis or rheumatoid arthritis. Journal of Clinical Epidemiology. 66: 546-56. PMID 23466017 DOI: 10.1016/J.Jclinepi.2012.12.009 |
0.609 |
|
| 2013 |
Widdifield J, Labrecque J, Lix L, Paterson JM, Bernatsky S, Tu K, Ivers N, Bombardier C. Systematic review and critical appraisal of validation studies to identify rheumatic diseases in health administrative databases. Arthritis Care & Research. 65: 1490-503. PMID 23436765 DOI: 10.1002/Acr.21993 |
0.611 |
|
| 2013 |
Hayden JA, van der Windt DA, Cartwright JL, Côté P, Bombardier C. Assessing bias in studies of prognostic factors. Annals of Internal Medicine. 158: 280-6. PMID 23420236 DOI: 10.7326/0003-4819-158-4-201302190-00009 |
0.319 |
|
| 2013 |
Bombardier C, Mian S. Quality indicators in rheumatoid arthritis care: using measurement to promote quality improvement. Annals of the Rheumatic Diseases. 72: ii128-31. PMID 23253925 DOI: 10.1136/Annrheumdis-2012-202259 |
0.368 |
|
| 2013 |
Widdifield J, Bernatsky S, Paterson JM, Gunraj N, Thorne JC, Pope J, Cividino A, Bombardier C. Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis. Arthritis Care & Research. 65: 353-61. PMID 22833532 DOI: 10.1002/Acr.21812 |
0.664 |
|
| 2013 |
Widdifield J, Paterson JM, Bernatsky S, Tu K, Thorne JC, Bombardier C. FRI0518 Epidemiology of rheumatoid arthritis in a universal public health care system: results from the ontario ra administrative database (ORAD). Annals of the Rheumatic Diseases. 72: A549.3-A550. DOI: 10.1136/Annrheumdis-2013-Eular.1645 |
0.638 |
|
| 2013 |
Widdifield J, Bernatsky S, Paterson J, Thorne J, Tu K, Bombardier C. FRI0410 Rheumatoid arthritis (RA) care: Geographic disparities and impact of primary care physicians on access to rheumatologists Annals of the Rheumatic Diseases. 71: 452.4-453. DOI: 10.1136/Annrheumdis-2012-Eular.2867 |
0.675 |
|
| 2012 |
Adams K, Bombardier C, van der Heijde DM. Safety of pain therapy during pregnancy and lactation in patients with inflammatory arthritis: a systematic literature review. The Journal of Rheumatology. Supplement. 90: 59-61. PMID 22942331 DOI: 10.3899/Jrheum.120344 |
0.329 |
|
| 2012 |
Adams K, Bombardier C, van der Heijde D. Safety and efficacy of on-demand versus continuous use of nonsteroidal antiinflammatory drugs in patients with inflammatory arthritis: a systematic literature review. The Journal of Rheumatology. Supplement. 90: 56-8. PMID 22942330 DOI: 10.3899/Jrheum.120343 |
0.359 |
|
| 2012 |
Hazlewood G, van der Heijde DM, Bombardier C. Paracetamol for the management of pain in inflammatory arthritis: a systematic literature review. The Journal of Rheumatology. Supplement. 90: 11-6. PMID 22942323 DOI: 10.3899/Jrheum.120336 |
0.32 |
|
| 2012 |
Englbrecht M, Tarner IH, van der Heijde DM, Manger B, Bombardier C, Müller-Ladner U. Measuring pain and efficacy of pain treatment in inflammatory arthritis: a systematic literature review. The Journal of Rheumatology. Supplement. 90: 3-10. PMID 22942322 DOI: 10.3899/Jrheum.120335 |
0.319 |
|
| 2012 |
Tavares R, Pope JE, Tremblay JL, Thorne C, Bykerk VP, Lazovskis J, Blocka KL, Bell MJ, Lacaille D, Hitchon CA, Fitzgerald AA, Fidler WK, Bookman AA, Henderson JM, Mosher DP, ... ... Bombardier C, et al. Time to disease-modifying antirheumatic drug treatment in rheumatoid arthritis and its predictors: a national, multicenter, retrospective cohort. The Journal of Rheumatology. 39: 2088-97. PMID 22896027 DOI: 10.3899/Jrheum.120100 |
0.406 |
|
| 2012 |
Bombardier C, Hazlewood GS, Akhavan P, Schieir O, Dooley A, Haraoui B, Khraishi M, Leclercq SA, Légaré J, Mosher DP, Pencharz J, Pope JE, Thomson J, Thorne C, Zummer M, et al. Canadian Rheumatology Association recommendations for the pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs: part II safety. The Journal of Rheumatology. 39: 1583-602. PMID 22707613 DOI: 10.3899/jrheum.120165 |
0.325 |
|
| 2012 |
Tubach F, Ravaud P, Martin-Mola E, Awada H, Bellamy N, Bombardier C, Felson DT, Hajjaj-Hassouni N, Hochberg M, Logeart I, Matucci-Cerinic M, Van De Laar M, Van Der Heijde D, Dougados M. Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: Results from a prospective multinational study Arthritis Care and Research. 64: 1699-1707. PMID 22674853 DOI: 10.1002/Acr.21747 |
0.357 |
|
| 2012 |
Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, Moreland LW, O'Dell J, Winthrop KL, Beukelman T, Bridges SL, Chatham WW, Paulus HE, Suarez-Almazor M, Bombardier C, et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care & Research. 64: 625-39. PMID 22473917 DOI: 10.1002/Acr.21641 |
0.43 |
|
| 2012 |
Whittle SL, Colebatch AN, Buchbinder R, Edwards CJ, Adams K, Englbrecht M, Hazlewood G, Marks JL, Radner H, Ramiro S, Richards BL, Tarner IH, Aletaha D, Bombardier C, Landewé RB, et al. Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e Initiative. Rheumatology (Oxford, England). 51: 1416-25. PMID 22447886 DOI: 10.1093/Rheumatology/Kes032 |
0.348 |
|
| 2012 |
Bombardier C, Barbieri M, Parthan A, Zack DJ, Walker V, Macarios D, Smolen JS. The relationship between joint damage and functional disability in rheumatoid arthritis: a systematic review. Annals of the Rheumatic Diseases. 71: 836-44. PMID 22128079 DOI: 10.1136/Annrheumdis-2011-200343 |
0.424 |
|
| 2012 |
Bykerk VP, Akhavan P, Hazlewood GS, Schieir O, Dooley A, Haraoui B, Khraishi M, Leclercq SA, Légaré J, Mosher DP, Pencharz J, Pope JE, Thomson J, Thorne C, Zummer M, ... Bombardier C, et al. Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs. The Journal of Rheumatology. 39: 1559-82. PMID 21921096 DOI: 10.3899/jrheum.110207 |
0.302 |
|
| 2011 |
Tang K, Beaton DE, Boonen A, Gignac MA, Bombardier C. Measures of work disability and productivity: Rheumatoid Arthritis Specific Work Productivity Survey (WPS-RA), Workplace Activity Limitations Scale (WALS), Work Instability Scale for Rheumatoid Arthritis (RA-WIS), Work Limitations Questionnaire (WLQ), and Work Productivity and Activity Impairment Questionnaire (WPAI). Arthritis Care & Research. 63: S337-49. PMID 22588755 DOI: 10.1002/Acr.20633 |
0.522 |
|
| 2011 |
Tavares R, Pope JE, Tremblay JL, Thorne C, Bykerk VP, Lazovskis J, Blocka KL, Bell MJ, Lacaille D, Hitchon CA, Fitzgerald AA, Fidler WK, Bookman AA, Henderson JM, Mosher DP, ... ... Bombardier C, et al. Early management of newly diagnosed rheumatoid arthritis by Canadian rheumatologists: a national, multicenter, retrospective cohort. The Journal of Rheumatology. 38: 2342-5. PMID 21885485 DOI: 10.3899/Jrheum.110249 |
0.356 |
|
| 2011 |
Tang K, Escorpizo R, Beaton DE, Bombardier C, Lacaille D, Zhang W, Anis AH, Boonen A, Verstappen SM, Buchbinder R, Osborne RH, Fautrel B, Gignac MA, Tugwell PS. Measuring the impact of arthritis on worker productivity: perspectives, methodologic issues, and contextual factors. The Journal of Rheumatology. 38: 1776-90. PMID 21807801 DOI: 10.3899/Jrheum.110405 |
0.461 |
|
| 2011 |
Jamal S, Alibhai SM, Badley EM, Bombardier C. Time to treatment for new patients with rheumatoid arthritis in a major metropolitan city. The Journal of Rheumatology. 38: 1282-8. PMID 21572157 DOI: 10.3899/jrheum.101315 |
0.334 |
|
| 2011 |
Tang K, Beaton DE, Gignac MA, Bombardier C. Rasch analysis informed modifications to the Work Instability Scale for Rheumatoid Arthritis for use in work-related upper limb disorders. Journal of Clinical Epidemiology. 64: 1242-51. PMID 21530170 DOI: 10.1016/J.Jclinepi.2011.02.002 |
0.531 |
|
| 2011 |
Silva-Fernández L, Castrejón I, Bombardier C, Carmona L. Diagnostic and prognostic value of genetics in undifferentiated peripheral inflammatory arthritis: a systematic review. The Journal of Rheumatology. Supplement. 87: 38-44. PMID 21364055 DOI: 10.3899/Jrheum.101073 |
0.311 |
|
| 2011 |
Koevoets R, Machado P, Bombardier C, van der Heijde DM. The value of conventional radiographs in undifferentiated arthritis: a systematic review. The Journal of Rheumatology. Supplement. 87: 26-30. PMID 21364053 DOI: 10.3899/Jrheum.101071 |
0.337 |
|
| 2011 |
Schoels M, Bombardier C, Aletaha D. Diagnostic and prognostic value of antibodies and soluble biomarkers in undifferentiated peripheral inflammatory arthritis: a systematic review. The Journal of Rheumatology. Supplement. 87: 20-5. PMID 21364052 DOI: 10.3899/Jrheum.101070 |
0.337 |
|
| 2011 |
Vercoutere W, Thevissen K, Bombardier C, Landewé RB. Diagnostic and predictive value of acute-phase reactants in adult undifferentiated peripheral inflammatory arthritis: a systematic review. The Journal of Rheumatology. Supplement. 87: 15-9. PMID 21364051 DOI: 10.3899/Jrheum.101069 |
0.303 |
|
| 2011 |
Kuriya B, Villeneuve E, Bombardier C. Diagnostic and prognostic value of history-taking and physical examination in undifferentiated peripheral inflammatory arthritis: a systematic review. The Journal of Rheumatology. Supplement. 87: 10-4. PMID 21364050 DOI: 10.3899/Jrheum.101098 |
0.332 |
|
| 2011 |
Villeneuve E, Kuriya B, Bombardier C. Patients considered as having undifferentiated peripheral inflammatory arthritis: a systematic review. The Journal of Rheumatology. Supplement. 87: 3-9. PMID 21364049 DOI: 10.3899/Jrheum.101068 |
0.372 |
|
| 2011 |
Bombardier C, van der Heijde DM. How to investigate and follow up undifferentiated peripheral inflammatory arthritis? 3e initiative 2008-2009: systematic reviews and clinical algorithm. The Journal of Rheumatology. Supplement. 87: 1-2. PMID 21364048 DOI: 10.3899/Jrheum.101067 |
0.389 |
|
| 2011 |
Pease C, Pope JE, Truong D, Bombardier C, Widdifield J, Thorne JC, Paul Haraoui B, Psaradellis E, Sampalis J, Bonner A. Comparison of anti-TNF treatment initiation in rheumatoid arthritis databases demonstrates wide country variability in patient parameters at initiation of anti-TNF therapy. Seminars in Arthritis and Rheumatism. 41: 81-9. PMID 21168187 DOI: 10.1016/J.Semarthrit.2010.09.004 |
0.656 |
|
| 2011 |
Salliot C, Finckh A, Katchamart W, Lu Y, Sun Y, Bombardier C, Keystone E. Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis. Annals of the Rheumatic Diseases. 70: 266-71. PMID 21097801 DOI: 10.1136/Ard.2010.132134 |
0.415 |
|
| 2011 |
Katchamart W, Faulkner A, Feldman B, Tomlinson G, Bombardier C. PubMed had a higher sensitivity than Ovid-MEDLINE in the search for systematic reviews. Journal of Clinical Epidemiology. 64: 805-7. PMID 20926257 DOI: 10.1016/J.Jclinepi.2010.06.004 |
0.439 |
|
| 2011 |
Borkhoff CM, Wieland ML, Myasoedova E, Ahmad Z, Welch V, Hawker GA, Li LC, Buchbinder R, Ueffing E, Beaton D, Cardiel MH, Gabriel SE, Guillemin F, Adebajo AO, Bombardier C, et al. Reaching those most in need: a scoping review of interventions to improve health care quality for disadvantaged populations with osteoarthritis. Arthritis Care & Research. 63: 39-52. PMID 20842715 DOI: 10.1002/Acr.20349 |
0.518 |
|
| 2011 |
Widdifield J, Bernatsky S, Paterson JM, Thorne JC, Cividino A, Pope J, Gunraj N, Bombardier C. Quality care in seniors with new-onset rheumatoid arthritis: a Canadian perspective. Arthritis Care & Research. 63: 53-7. PMID 20806274 DOI: 10.1002/Acr.20304 |
0.683 |
|
| 2011 |
Van Der Velde G, Pham B, MacHado M, Ieraci L, Witteman W, Bombardier C, Krahn M. Cost-effectiveness of biologic response modifiers compared to disease-modifying antirheumatic drugs for rheumatoid arthritis: A systematic review Arthritis Care and Research. 63: 65-78. PMID 20740606 DOI: 10.1002/Acr.20338 |
0.378 |
|
| 2011 |
Machado P, Castrejon I, Katchamart W, Koevoets R, Kuriya B, Schoels M, Silva-Fernández L, Thevissen K, Vercoutere W, Villeneuve E, Aletaha D, Carmona L, Landewé R, van der Heijde D, Bijlsma JW, ... ... Bombardier C, et al. Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Annals of the Rheumatic Diseases. 70: 15-24. PMID 20724311 DOI: 10.1136/Ard.2010.130625 |
0.359 |
|
| 2011 |
Gossec L, Bijlsma JW, Bombardier C, Canhão H, Devlin J, Edwards CJ, Hamuryudan V, Kvien TK, Leeb BF, Martín-Mola EM, Mielants H, Müller-Ladner U, Ostergaard M, Pereira IA, Ramos-Remus C, et al. Dissemination and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: results of a study among 2233 rheumatologists. Annals of the Rheumatic Diseases. 70: 388-9. PMID 20472594 DOI: 10.1136/Ard.2010.128652 |
0.324 |
|
| 2010 |
Pease C, Pope JE, Thorne C, Haraoui BP, Truong D, Bombardier C, Widdifield J, Psaradellis E, Sampalis JS, Bonner A. Canadian variation by province in rheumatoid arthritis initiating anti-tumor necrosis factor therapy: results from the optimization of adalimumab trial. The Journal of Rheumatology. 37: 2469-74. PMID 20843910 DOI: 10.3899/Jrheum.091447 |
0.647 |
|
| 2010 |
Tang K, Beaton DE, Gignac MA, Lacaille D, Zhang W, Bombardier C. The Work Instability Scale for rheumatoid arthritis predicts arthritis-related work transitions within 12 months. Arthritis Care & Research. 62: 1578-87. PMID 20521332 DOI: 10.1002/Acr.20272 |
0.569 |
|
| 2010 |
Katchamart W, Bourré-Tessier J, Donka T, Drouin J, Rohekar G, Bykerk VP, Haraoui B, LeClerq S, Mosher DP, Pope JE, Shojania K, Thomson J, Thorne JC, Bombardier C, Blocka K, et al. Canadian recommendations for use of methotrexate in patients with rheumatoid arthritis Journal of Rheumatology. 37: 1422-1430. PMID 20516029 DOI: 10.3899/Jrheum.090978 |
0.448 |
|
| 2010 |
Katchamart W, Bombardier C. Systematic monitoring of disease activity using an outcome measure improves outcomes in rheumatoid arthritis. The Journal of Rheumatology. 37: 1411-5. PMID 20436069 DOI: 10.3899/Jrheum.090980 |
0.425 |
|
| 2010 |
Tang K, Beaton DE, Lacaille D, Gignac MA, Zhang W, Anis AH, Bombardier C. The Work Instability Scale for Rheumatoid Arthritis (RA-WIS): Does it work in osteoarthritis? Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 19: 1057-68. PMID 20419502 DOI: 10.1007/S11136-010-9656-Y |
0.579 |
|
| 2010 |
Katchamart W, Trudeau J, Phumethum V, Bombardier C. Methotrexate monotherapy versus methotrexate combination therapy with non-biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis. The Cochrane Database of Systematic Reviews. CD008495. PMID 20393970 DOI: 10.1002/14651858.Cd008495 |
0.413 |
|
| 2010 |
Katchamart W, Johnson S, Lin HJ, Phumethum V, Salliot C, Bombardier C. Predictors for remission in rheumatoid arthritis patients: A systematic review. Arthritis Care & Research. 62: 1128-43. PMID 20235210 DOI: 10.1002/acr.20188 |
0.356 |
|
| 2010 |
Beaton DE, Tang K, Gignac MA, Lacaille D, Badley EM, Anis AH, Bombardier C. Reliability, validity, and responsiveness of five at-work productivity measures in patients with rheumatoid arthritis or osteoarthritis. Arthritis Care & Research. 62: 28-37. PMID 20191488 DOI: 10.1002/Acr.20011 |
0.556 |
|
| 2010 |
Salliot C, Bombardier C, Saraux A, Combe B, Dougados M. Hormonal replacement therapy may reduce the risk for RA in women with early arthritis who carry HLA-DRB1 *01 and/or *04 alleles by protecting against the production of anti-CCP: results from the ESPOIR cohort. Annals of the Rheumatic Diseases. 69: 1683-6. PMID 19740903 DOI: 10.1136/Ard.2009.111179 |
0.378 |
|
| 2009 |
Beaton D, Bombardier C, Escorpizo R, Zhang W, Lacaille D, Boonen A, Osborne RH, Anis AH, Strand CV, Tugwell PS. Measuring worker productivity: frameworks and measures. The Journal of Rheumatology. 36: 2100-9. PMID 19738221 DOI: 10.3899/Jrheum.090366 |
0.507 |
|
| 2009 |
Bernatsky S, Paterson M, Thorne C, Cividino A, Pope J, Hux J, Bombardier C. Potential effects of a national consensus statement on optimal treatment of early rheumatoid arthritis in Ontario Scandinavian Journal of Rheumatology. 38: 390-391. PMID 19579090 DOI: 10.1080/03009740902842190 |
0.362 |
|
| 2009 |
Ammendolia C, Côté P, Hogg-Johnson S, Bombardier C. Utilization and costs of lumbar and full spine radiography by Ontario chiropractors from 1994 to 2001. The Spine Journal : Official Journal of the North American Spine Society. 9: 556-63. PMID 19447076 DOI: 10.1016/J.Spinee.2009.03.009 |
0.315 |
|
| 2009 |
Katchamart W, Trudeau J, Phumethum V, Bombardier C. Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: A systematic review and meta-analysis Annals of the Rheumatic Diseases. 68: 1105-1112. PMID 19054823 DOI: 10.1136/Ard.2008.099861 |
0.37 |
|
| 2009 |
Visser K, Katchamart W, Loza E, Martinez-Lopez JA, Salliot C, Trudeau J, Bombardier C, Carmona L, van der Heijde D, Bijlsma JW, Boumpas DT, Canhao H, Edwards CJ, Hamuryudan V, Kvien TK, et al. Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Annals of the Rheumatic Diseases. 68: 1086-93. PMID 19033291 DOI: 10.1136/Ard.2008.094474 |
0.343 |
|
| 2008 |
Aletaha D, Landewe R, Karonitsch T, Bathon J, Boers M, Bombardier C, Bombardieri S, Choi H, Combe B, Dougados M, Emery P, Gomez-Reino J, Keystone E, Koch G, Kvien TK, et al. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Arthritis and Rheumatism. 59: 1371-7. PMID 18821648 DOI: 10.1002/Art.24123 |
0.435 |
|
| 2008 |
Aletaha D, Landewe R, Karonitsch T, Bathon J, Boers M, Bombardier C, Bombardieri S, Choi H, Combe B, Dougados M, Emery P, Gomez-Reino J, Keystone E, Koch G, Kvien TK, et al. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Annals of the Rheumatic Diseases. 67: 1360-4. PMID 18791055 DOI: 10.1136/Ard.2008.091454 |
0.435 |
|
| 2008 |
Li LC, Badley EM, MacKay C, Mosher D, Jamal SW, Jones A, Bombardier C. An evidence-informed, integrated framework for rheumatoid arthritis care. Arthritis and Rheumatism. 59: 1171-83. PMID 18668611 DOI: 10.1002/Art.23931 |
0.409 |
|
| 2007 |
Michaud K, Bombardier C, Emery P. Quality of life in patients with rheumatoid arthritis: Does abatacept make a difference? Clinical and Experimental Rheumatology. 25. PMID 17977487 |
0.365 |
|
| 2007 |
Beresniak A, Russell AS, Haraoui B, Bessette L, Bombardier C, Duru G. Advantages and limitations of utility assessment methods in rheumatoid arthritis. The Journal of Rheumatology. 34: 2193-200. PMID 17937471 |
0.313 |
|
| 2007 |
Escorpizo R, Bombardier C, Boonen A, Hazes JM, Lacaille D, Strand V, Beaton D. Worker productivity outcome measures in arthritis. The Journal of Rheumatology. 34: 1372-80. PMID 17552063 |
0.489 |
|
| 2007 |
Lee HS, Irigoyen P, Kern M, Lee A, Batliwalla F, Khalili H, Wolfe F, Lum RF, Massarotti E, Weisman M, Bombardier C, Karlson EW, Criswell LA, Vlietinck R, Gregersen PK. Interaction between smoking, the shared epitope, and anti-cyclic citrullinated peptide: a mixed picture in three large North American rheumatoid arthritis cohorts. Arthritis and Rheumatism. 56: 1745-53. PMID 17530703 DOI: 10.1002/Art.22703 |
0.349 |
|
| 2007 |
Tubach F, Ravaud P, Beaton D, Boers M, Bombardier C, Felson DT, van der Heijde D, Wells G, Dougados M. Minimal clinically important improvement and patient acceptable symptom state for subjective outcome measures in rheumatic disorders. The Journal of Rheumatology. 34: 1188-93. PMID 17477485 |
0.484 |
|
| 2007 |
Beaton DE, Bombardier C, Cole DC, Hogg-Johnson S, Van Eerd D, Amadio PC, Buchbinder R, Carette S, Evanoff BA, Kennedy C, Novak CB, Pransky G, Viikari-Juntura E. A pattern recognition approach to the development of a classification system for upper-limb musculoskeletal disorders of workers Scandinavian Journal of Work, Environment and Health. 33: 131-139. PMID 17460801 DOI: 10.5271/Sjweh.1116 |
0.498 |
|
| 2007 |
Felson D, Aletaha D, Anderson J, Bathon J, Boers M, Bombardier C, Choi H, Dougados M, Furst D, Koch G, Landewé R, LaValley M, Michaud K, Paulus H, Pincus T, et al. A proposed revision to the ACR20: The hybrid measure of American College of Rheumatology response Arthritis Care and Research. 57: 193-202. PMID 17330293 DOI: 10.1002/Art.22552 |
0.41 |
|
| 2006 |
Li LC, Maetzel A, Davis AM, Lineker SC, Bombardier C, Coyte PC. Primary therapist model for patients referred for rheumatoid arthritis rehabilitation: a cost-effectiveness analysis. Arthritis and Rheumatism. 55: 402-10. PMID 16739183 DOI: 10.1002/Art.21989 |
0.689 |
|
| 2006 |
Li LC, Davis AM, Lineker SC, Coyte PC, Bombardier C. Effectiveness of the primary therapist model for rheumatoid arthritis rehabilitation: a randomized controlled trial. Arthritis and Rheumatism. 55: 42-52. PMID 16463410 DOI: 10.1002/Art.21692 |
0.396 |
|
| 2005 |
Irigoyen P, Lee AT, Wener MH, Li W, Kern M, Batliwalla F, Lum RF, Massarotti E, Weisman M, Bombardier C, Remmers EF, Kastner DL, Seldin MF, Criswell LA, Gregersen PK. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles. Arthritis and Rheumatism. 52: 3813-8. PMID 16320316 DOI: 10.1002/Art.21419 |
0.366 |
|
| 2005 |
Wells GA, Boers M, Shea B, Brooks PM, Simon LS, Strand CV, Aletaha D, Anderson JJ, Bombardier C, Dougados M, Emery P, Felson DT, Fransen J, Furst DE, Hazes JM, et al. Minimal disease activity for rheumatoid arthritis: a preliminary definition. The Journal of Rheumatology. 32: 2016-24. PMID 16206362 |
0.345 |
|
| 2005 |
Heymans MW, Tulder MWV, Esmail R, Bombardier C, Koes BW. Back schools for nonspecific low back pain : A systematic review within the framework of the Cochrane Collaboration Back Review Group Spine. 30: 2153-2163. PMID 16205340 DOI: 10.1097/01.Brs.0000182227.33627.15 |
0.318 |
|
| 2005 |
Marshall JC, Vincent JL, Guyatt G, Angus DC, Abraham E, Bernard G, Bombardier C, Calandra T, Jørgensen HS, Sylvester R, Boers M. Outcome measures for clinical research in sepsis: a report of the 2nd Cambridge Colloquium of the International Sepsis Forum. Critical Care Medicine. 33: 1708-16. PMID 16096445 DOI: 10.1097/01.Ccm.0000174478.70338.03 |
0.321 |
|
| 2005 |
Ammendolia C, Kerr MS, Bombardier C. Back belt use for prevention of occupational low back pain: a systematic review. Journal of Manipulative and Physiological Therapeutics. 28: 128-34. PMID 15800513 DOI: 10.1016/J.Jmpt.2005.01.009 |
0.337 |
|
| 2005 |
Lee AT, Li W, Liew A, Bombardier C, Weisman M, Massarotti EM, Kent J, Wolfe F, Begovich AB, Gregersen PK. The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status Genes and Immunity. 6: 129-133. PMID 15674368 DOI: 10.1038/Sj.Gene.6364159 |
0.36 |
|
| 2005 |
Zangger P, Kachura JR, Bombardier C, Redelmeier DA, Badley EM, Bogoch ER. Assessing damage in individual joints in rheumatoid arthritis: a new method based on the Larsen system. Joint Bone Spine. 71: 389-96. PMID 15474390 DOI: 10.1016/J.Jbspin.2003.07.009 |
0.388 |
|
| 2005 |
Tubach F, Ravaud P, Baron G, Falissard B, Logeart I, Bellamy N, Bombardier C, Felson D, Hochberg M, Heijde Dvd, Dougados M. Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement Annals of the Rheumatic Diseases. 64: 29-33. PMID 15208174 DOI: 10.1136/Ard.2004.022905 |
0.368 |
|
| 2005 |
Tubach F, Ravaud P, Baron G, Falissard B, Logeart I, Bellamy N, Bombardier C, Felson D, Hochberg M, Heijde Dvd, Dougados M. Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state Annals of the Rheumatic Diseases. 64: 34-37. PMID 15130902 DOI: 10.1136/Ard.2004.023028 |
0.365 |
|
| 2005 |
Li LC, Davis AM, Lineker S, Coyte PC, Bombardier C. Outcomes of Home-Based Rehabilitation Provided by Primary Therapists for Patients with Rheumatoid Arthritis: Pilot Study Physiotherapy Canada. 57: 255-264. DOI: 10.3138/Ptc.57.4.255 |
0.453 |
|
| 2004 |
Heymans MW, Tulder MWv, Esmail R, Bombardier C, Koes BW. Back schools for non‐specific low‐back pain Cochrane Database of Systematic Reviews. CD000261. PMID 15494995 DOI: 10.1002/14651858.Cd000261.Pub2 |
0.318 |
|
| 2004 |
Li LC, Maetzel A, Pencharz JN, Maguire L, Bombardier C. Use of mainstream nonpharmacologic treatment by patients with arthritis. Arthritis and Rheumatism. 51: 203-9. PMID 15077260 DOI: 10.1002/Art.20244 |
0.707 |
|
| 2004 |
Maetzel A, Li LC, Pencharz J, Tomlinson G, Bombardier C. The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study. Annals of the Rheumatic Diseases. 63: 395-401. PMID 15020333 DOI: 10.1136/Ard.2003.006031 |
0.685 |
|
| 2003 |
Van Eerd D, Beaton D, Cole D, Lucas J, Hogg-Johnson S, Bombardier C. Classification systems for upper-limb musculoskeletal disorders in workers: a review of the literature. Journal of Clinical Epidemiology. 56: 925-36. PMID 14568622 DOI: 10.1016/S0895-4356(03)00122-7 |
0.468 |
|
| 2003 |
Li L, Bombardier C. Utilization of Physiotherapy and Occupational Therapy by Ontario Rheumatologists in Managing Rheumatoid Arthritis: A Survey Physiotherapy Canada. 55: 23. DOI: 10.2310/6640.2003.35246 |
0.354 |
|
| 2002 |
Maetzel A, Strand V, Tugwell P, Wells G, Bombardier C. Cost effectiveness of adding leflunomide to a 5-year strategy of conventional disease-modifying antirheumatic drugs in patients with rheumatoid arthritis. Arthritis and Rheumatism. 47: 655-61. PMID 12522841 DOI: 10.1002/Art.10793 |
0.658 |
|
| 2002 |
Ammendolia C, Bombardier C, Hogg-Johnson S, Glazier R. Views on radiography use for patients with acute low back pain among chiropractors in an Ontario community. Journal of Manipulative and Physiological Therapeutics. 25: 511-520. PMID 12381973 DOI: 10.1067/Mmt.2002.127075 |
0.308 |
|
| 2002 |
Laine L, Bombardier C, Hawkey CJ, Davis BR, Shapiro D, Brett C, Reicin A. Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis. Gastroenterology. 123: 1006-1012. PMID 12360461 DOI: 10.1053/Gast.2002.36013 |
0.331 |
|
| 2002 |
Bombardier C. An evidence-based evaluation of the gastrointestinal safety of coxibs ☆ American Journal of Cardiology. 89: 3-9. PMID 11909555 DOI: 10.1016/S0002-9149(02)02231-2 |
0.343 |
|
| 2002 |
Guzman J, Esmail R, Karjalainen KA, Malmivaara A, Irvin E, Bombardier C. Multidisciplinary bio-psycho-social rehabilitation for chronic low-back pain Cochrane Database of Systematic Reviews. CD000963. PMID 11869581 DOI: 10.1002/14651858.Cd000963 |
0.336 |
|
| 2002 |
Maetzel A, Strand V, Tugwell P, Wells G, Bombardier C. Economic comparison of leflunomide and methotrexate in patients with rheumatoid arthritis: an evaluation based on a 1-year randomised controlled trial. Pharmacoeconomics. 20: 61-70. PMID 11817993 DOI: 10.2165/00019053-200220010-00006 |
0.679 |
|
| 2001 |
Pencharz JN, Grigoriadis E, Jansz GF, Bombardier C. A critical appraisal of clinical practice guidelines for the treatment of lower-limb osteoarthritis Arthritis Research & Therapy. 4: 36-44. PMID 11879536 DOI: 10.1186/Ar381 |
0.32 |
|
| 2001 |
Beaton DE, Bombardier C, Katz JN, Wright JG. A taxonomy for responsiveness. Journal of Clinical Epidemiology. 54: 1204-17. PMID 11750189 DOI: 10.1016/S0895-4356(01)00407-3 |
0.498 |
|
| 2001 |
Guzmán J, Esmail R, Karjalainen K, Malmivaara A, Irvin E, Bombardier C. Multidisciplinary rehabilitation for chronic low back pain: systematic review. Bmj. 322: 1511-1516. PMID 11420271 DOI: 10.1136/Bmj.322.7301.1511 |
0.312 |
|
| 2001 |
Beaton DE, Tarasuk V, Katz JN, Wright JG, Bombardier C. "Are you better?" A qualitative study of the meaning of recovery. Arthritis and Rheumatism. 45: 270-9. PMID 11409669 DOI: 10.1002/1529-0131(200106)45:3<270::Aid-Art260>3.0.Co;2-T |
0.493 |
|
| 2001 |
Beaton DE, Katz JN, Fossel AH, Wright JG, Tarasuk V, Bombardier C. Measuring the whole or the parts? Validity, reliability, and responsiveness of the Disabilities of the Arm, Shoulder and Hand outcome measure in different regions of the upper extremity. Journal of Hand Therapy : Official Journal of the American Society of Hand Therapists. 14: 128-46. PMID 11382253 DOI: 10.1016/S0894-1130(01)80043-0 |
0.492 |
|
| 2001 |
Marx RG, Hogg-Johnson S, Hudak P, Beaton D, Shields S, Bombardier C, Wright JG. A comparison of patients' responses about their disability with and without attribution to their affected area. Journal of Clinical Epidemiology. 54: 580-586. PMID 11377118 DOI: 10.1016/S0895-4356(00)00345-0 |
0.518 |
|
| 2001 |
Gabriel S, Drummond M, Suarez-Almazor ME, Ruff B, Guillemin F, Bombardier C, Boers M, Maetzel A, Ruof J, Cranney A, Marentette M, Tugwell P. OMERACT 5 Economics Working Group: summary, recommendations, and research agenda. The Journal of Rheumatology. 28: 670-3. PMID 11296980 |
0.572 |
|
| 2001 |
Bombardier C, Hayden J, Beaton DE. Minimal clinically important difference. Low back pain: outcome measures. The Journal of Rheumatology. 28: 431-8. PMID 11246692 |
0.476 |
|
| 2001 |
Beaton DE, Bombardier C, Katz JN, Wright JG, Wells G, Boers M, Strand V, Shea B. Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome Measures in Rheumatology. Minimal Clinically Important Difference. The Journal of Rheumatology. 28: 400-5. PMID 11246687 |
0.445 |
|
| 2001 |
Bombardier C, Hochberg M, Laine L, Ramey, Reicin A, Watson D. SAT0255 Regional variation in baseline patient characteristics and disease management of rheumatoid arthritis patients in the vigour (vioxx gi outcomes research) study Annals of the Rheumatic Diseases. 60. DOI: 10.1136/Annrheumdis-2001.891 |
0.389 |
|
| 2001 |
Bombardier C, Hochberg M, Laine L, Ramey, Reicin A, Watson D. SAT0254 Patient characteristics and disease management of rheumatoid arthritis at baseline in the vigour (vioxx gi outcomes research) study: effects of disease duration Annals of the Rheumatic Diseases. 60. DOI: 10.1136/Annrheumdis-2001.890 |
0.394 |
|
| 2000 |
Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine. 25: 3186-91. PMID 11124735 DOI: 10.1097/00007632-200012150-00014 |
0.472 |
|
| 2000 |
Bombardier C. Outcome assessments in the evaluation of treatment of spinal disorders: summary and general recommendations. Spine. 25: 3100-3103. PMID 11124724 DOI: 10.1097/00007632-200012150-00003 |
0.348 |
|
| 2000 |
Maetzel A, Wong A, Strand V, Tugwell P, Wells G, Bombardier C. Meta-analysis of treatment termination rates among rheumatoid arthritis patients receiving disease-modifying anti-rheumatic drugs. Rheumatology (Oxford, England). 39: 975-81. PMID 10986302 DOI: 10.1093/Rheumatology/39.9.975 |
0.714 |
|
| 2000 |
Maetzel A, Johnson SH, Woodbury M, Bombardier C. Use of grade membership analysis to profile the practice styles of individual physicians in the management of acute low back pain. Journal of Clinical Epidemiology. 53: 195-205. PMID 10729692 DOI: 10.1016/S0895-4356(99)00120-1 |
0.631 |
|
| 2000 |
Tugwell P, Wells G, Strand V, Maetzel A, Bombardier C, Crawford B, Dorrier C, Thompson A, Tindall E, Offenberg H, Poiley J, Rutstein J, Dietz F, Brodsky A, Harris R, et al. Clinical improvement as reflected in measures of function and health- related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: Sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial Arthritis and Rheumatism. 43: 506-514. PMID 10728742 DOI: 10.1002/1529-0131(200003)43:3<506::Aid-Anr5>3.0.Co;2-U |
0.67 |
|
| 2000 |
McIntosh G, Frank J, Hogg-Johnson S, Bombardier C, Hall H. 1999 Young Investigator Research Award Winner : Prognostic Factors for Time Receiving Workers' Compensation Benefits in a Cohort of Patients With Low Back Pain Spine. 25: 147-157. PMID 10685477 DOI: 10.1097/00007632-200001150-00003 |
0.305 |
|
| 2000 |
Beaton DE, Cole DC, Manno M, Bombardier C, Hogg-Johnson S, Shannon HS. Describing the burden of upper-extremity musculoskeletal disorders in newspaper workers: What difference do case definitions make? Journal of Occupational Rehabilitation. 10: 39-53. DOI: 10.1023/A:1009489712094 |
0.507 |
|
| 2000 |
McIntosh G, Frank J, Hogg-Johnson S, Hall H, Bombardier C. Low Back Pain Prognosis: Structured Review of the Literature Journal of Occupational Rehabilitation. 10: 101-115. DOI: 10.1023/A:1009450102876 |
0.309 |
|
| 1999 |
Davis AM, Beaton DE, Hudak P, Amadio P, Bombardier C, Cole D, Hawker G, Katz JN, Makela M, Marx RG, Punnett L, Wright JG. Measuring disability of the upper extremity: a rationale supporting the use of a regional outcome measure. Journal of Hand Therapy : Official Journal of the American Society of Hand Therapists. 12: 269-74. PMID 10622192 DOI: 10.1016/S0894-1130(99)80063-5 |
0.481 |
|
| 1999 |
Bombardier C, Maetzel A. Pharmacoeconomic evaluation of new treatments: efficacy versus effectiveness studies? Annals of the Rheumatic Diseases. 58: I82-5. PMID 10577979 |
0.619 |
|
| 1999 |
Maetzel A, Bombardier C. Give observational studies a chance: better observational studies make better economic evaluations. The Journal of Rheumatology. 26: 2298-9. PMID 10555880 |
0.573 |
|
| 1999 |
Strand V, Tugwell P, Bombardier C, Maetzel A, Crawford B, Dorrier C, Thompson A, Wells G. Function and health-related quality of life: results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group. Arthritis and Rheumatism. 42: 1870-8. PMID 10513801 DOI: 10.1002/1529-0131(199909)42:9<1870::Aid-Anr11>3.0.Co;2-D |
0.704 |
|
| 1999 |
Brunner HI, Feldman BM, Bombardier C, Silverman ED. Sensitivity of the systemic lupus erythematosus disease activity index, British Isles lupus assessment group index, and systemic lupus activity measure in the evaluation of clinical change in childhood‐onset systemic lupus erythematosus Arthritis & Rheumatism. 42: 1354-1360. PMID 10403262 DOI: 10.1002/1529-0131(199907)42:7<1354::Aid-Anr8>3.0.Co;2-4 |
0.311 |
|
| 1999 |
Guzmán J, Peloso P, Bombardier C. Capturing health care utilization after occupational low-back pain: development of an interviewer-administered questionnaire. Journal of Clinical Epidemiology. 52: 419-427. PMID 10360337 DOI: 10.1016/S0895-4356(99)00013-X |
0.317 |
|
| 1998 |
Maetzel A, Bombardier C, Strand V, Tugwell P, Wells G. How Canadian and US rheumatologists treat moderate or aggressive rheumatoid arthritis: a survey. The Journal of Rheumatology. 25: 2331-8. PMID 9858426 |
0.684 |
|
| 1998 |
Deyo RA, Battie M, Beurskens AJHM, Bombardier C, Croft P, Koes B, Malmivaara A, Roland M, Korff MV, Waddell G. Outcome measures for low back pain research. A proposal for standardized use. Spine. 23: 2003-2013. PMID 9779535 DOI: 10.1097/00007632-199809150-00018 |
0.342 |
|
| 1998 |
Maetzel A, Ferraz MB, Bombardier C. A review of cost-effectiveness analyses in rheumatology and related disciplines. Current Opinion in Rheumatology. 10: 136-40. PMID 9567209 DOI: 10.1097/00002281-199803000-00009 |
0.662 |
|
| 1998 |
Hawker G, Wright J, Coyte P, Paul J, Dittus R, Croxford R, Katz B, Bombardier C, Heck D, Freund D. Health-related quality of life after knee replacement. The Journal of Bone and Joint Surgery. American Volume. 80: 163-73. PMID 9486722 DOI: 10.2106/00004623-199802000-00003 |
0.31 |
|
| 1998 |
Maetzel A, Ferraz MB, Bombardier C. The cost-effectiveness of misoprostol in preventing serious gastrointestinal events associated with the use of nonsteroidal antiinflammatory drugs. Arthritis and Rheumatism. 41: 16-25. PMID 9433865 DOI: 10.1002/1529-0131(199801)41:1<16::Aid-Art3>3.0.Co;2-4 |
0.689 |
|
| 1997 |
Clark P, Tugwell P, Bennet K, Bombardier C, Shea B, Wells G, Suarez-Almazor ME. Injectable gold for rheumatoid arthritis. Cochrane Database of Systematic Reviews. 1997. PMID 10796386 DOI: 10.1002/14651858.Cd000520 |
0.433 |
|
| 1997 |
Ferraz MB, Maetzel A, Bombardier C. A summary of economic evaluations published in the field of rheumatology and related disciplines. Arthritis and Rheumatism. 40: 1587-93. PMID 9324012 DOI: 10.1002/Art.1780400907 |
0.63 |
|
| 1997 |
Maetzel A, Mäkelä M, Hawker G, Bombardier C. Osteoarthritis of the hip and knee and mechanical occupational exposure--a systematic overview of the evidence. The Journal of Rheumatology. 24: 1599-607. PMID 9263158 |
0.585 |
|
| 1997 |
Beaton DE, Hogg-Johnson S, Bombardier C. Evaluating changes in health status: reliability and responsiveness of five generic health status measures in workers with musculoskeletal disorders. Journal of Clinical Epidemiology. 50: 79-93. PMID 9048693 DOI: 10.1016/S0895-4356(96)00296-X |
0.49 |
|
| 1996 |
Davis AM, Wright JG, Williams JI, Bombardier C, Griffin A, Bell RS. Development of a measure of physical function for patients with bone and soft tissue sarcoma. Quality of Life Research. 5: 508-516. PMID 8973131 DOI: 10.1007/Bf00540024 |
0.311 |
|
| 1996 |
Beaton DE, Bombardier C, Hogg-Johnson SA. Measuring health in injured workers: a cross-sectional comparison of five generic health status instruments in workers with musculoskeletal injuries. American Journal of Industrial Medicine. 29: 618-31. PMID 8773722 DOI: 10.1002/(Sici)1097-0274(199606)29:6<618::Aid-Ajim6>3.0.Co;2-F |
0.497 |
|
| 1996 |
Hudak PL, Amadio PC, Bombardier C. Development of an upper extremity outcome measure: The DASH (disabilities of the arm, shoulder, and head) American Journal of Industrial Medicine. 29: 602-608. PMID 8773720 DOI: 10.1002/(Sici)1097-0274(199606)29:6<602::Aid-Ajim4>3.0.Co;2-L |
0.311 |
|
| 1996 |
Ferraz MB, Maetzel A, Bombardier C. Critical appraisal of economic evaluations published in the field of rheumatology and related disciplines Journal of Clinical Epidemiology. 49: S18. DOI: 10.1016/0895-4356(96)89221-3 |
0.607 |
|
| 1995 |
Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, Katz LM, Lightfoot R, Paulus H, Strand V. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis and Rheumatism. 38: 727-35. PMID 7779114 DOI: 10.1002/Art.1780380602 |
0.456 |
|
| 1995 |
Buchbinder R, Bombardier C, Yeung M, Tugwell P. Which outcome measures should be used in rheumatoid arthritis clinical trials? Clinical and quality-of-life measures' responsiveness to treatment in a randomized controlled trial. Arthritis and Rheumatism. 38: 1568-80. PMID 7488277 DOI: 10.1002/Art.1780381108 |
0.401 |
|
| 1994 |
Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. Journal of Clinical Epidemiology. 46: 1417-32. PMID 8263569 DOI: 10.1016/0895-4356(93)90142-N |
0.496 |
|
| 1994 |
Bombardier C, Kerr MS, Shannon HS, Frank JW. A guide to interpreting epidemiologic studies on the etiology of back pain. Spine. 19: 2047S-2056S. PMID 7801182 DOI: 10.1097/00007632-199409151-00006 |
0.32 |
|
| 1994 |
Fries JF, Hochberg MC, Medsger TA, Hunder GG, Bombardier C, Altman RD, Arnett FC, Cassidy JT, Gladman DD, Lightfoot RW, Schwartz BD, White B. Criteria for rheumatic disease: Different types and different functions Arthritis and Rheumatism. 37: 454-462. PMID 7605403 DOI: 10.1002/Art.1780370403 |
0.32 |
|
| 1994 |
Guillemin F, Bombardier C, Beaton D. Response Journal of Clinical Epidemiology. 47: 1466. DOI: 10.1016/0895-4356(94)90092-2 |
0.439 |
|
| 1992 |
Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, Austin HA, Bell DA, Bloch DA, Corey PN, Decker JL, Esdaile J, Fries JF, Ginzler EM, Goldsmith CH, Hochberg MC, et al. Derivation of the SLEDAI: A disease activity index for lupus patients Arthritis and Rheumatism. 35: 630-640. PMID 1599520 DOI: 10.1002/Art.1780350606 |
0.301 |
|
| 1992 |
Bombardier C, Buchbinder R, Tugwell P. Efficacy of cyclosporin A in rheumatoid arthritis: long-term follow-up data and the effect on quality of life. Scandinavian Journal of Rheumatology. 21: 29-33. PMID 1475631 DOI: 10.3109/03009749209101480 |
0.331 |
|
| 1990 |
Bell MJ, Bombardier C, Tugwell P. Measurement of functional status, quality of life, and utility in rheumatoid arthritis. Arthritis & Rheumatism. 33: 591-601. PMID 2183806 DOI: 10.1002/Art.1780330420 |
0.37 |
|
| 1987 |
Gladman DD, Bombardier C. Sickle cell crisis following intraarticular steroid therapy for rheumatoid arthritis Arthritis and Rheumatism. 30: 1065-1068. PMID 3663256 DOI: 10.1002/Art.1780300916 |
0.381 |
|
| 1986 |
Bombardier C, Ware J, Russell IJ, Larson M, Chalmers A, Read JL, Arnold W, Bennett R, Caldwell J, Hench PK, Lages W, Liang M, Ludivico C, Morgan GJ, O'Hanlan M, et al. Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial The American Journal of Medicine. 81: 565-578. PMID 3532786 DOI: 10.1016/0002-9343(86)90539-5 |
0.386 |
|
| Show low-probability matches. |